Introduction
The epidemiological burden of heart failure (HF) is tremendous, with an estimated 26 million people affected worldwide, leading some to describe it as a global epidemic.
1,2 Despite this, data on prevalence and, in particular, incidence of HF often lack validity and consistency. 2 Reported prevalence rates of HF vary over a wide range, highlighting the need for a detailed description The annual number of hospitalizations is higher in Germany, compared with other European countries. 1 Hence, large amounts of data on inpatients with HF have been collected and well documented. 3, 4 To extend the existing epidemiological data on HF, we analysed temporal trends of HF-related hospitalizations, hospital days and in-hospital deaths in Germany during a 14-year period (2000) (2001) (2002) (2003) (2004) (2005) (2006) (2007) (2008) (2009) (2010) (2011) (2012) (2013) .
Methods

Data source
Administrative data on inpatients with HF in Germany were obtained from the German Federal Health Monitoring System (Gesundheitsberichterstattung des Bundes), an annual census of inpatient characteristics in all German hospitals provided by the Federal Statistical Office. 4 Data were selected using the primary discharge diagnosis 'heart failure' (HF, I50) using the German Modification of ICD-10 (ICD-10-GM). Data collection is mandatory owing to regulatory requirements. Statistical information includes sex, age, primary diagnosis at the time of discharge from the hospital, place of residence and treatment, length of stay, and vital status at discharge. 3, 4 Ethics statement Ethical approval was waived by the Ethics Committee of the Friedrich-Alexander-University Erlangen-Nuremberg, Germany, because of the retrospective nature of this analysis, which was conducted in accordance with the Declaration of Helsinki. All data have been routinely collected during clinical practice, therefore written and informed consent from subjects under study for anonymized storage of information and its use for research was not needed.
Data extraction and analysis
The analyses cover a period of 14 years (2000-2013) and use the most recent data available. The database comprises all hospitalized HF cases identified by the primary discharge diagnosis code for HF (I50) according to ICD-10 (before 2004) and ICD-10-GM (starting with 2004). In Germany, 'heart failure' is coded using a five-digit code, which includes additional information to the coding according ICD-10-WHO (World Health Organization) [e.g. the severity of HF using New York Heart Association (NYHA) class]. The Federal Statistical Office of Germany aggregates the five-digit codes and a three-digit code is being published (http://www.gbe-bund.de/gbe10/pkg_isgbe5.prc_isgbe?p_uid=gast &p_aid=0&p_sprache=D, accessed November 2015). Discharge diagnosis of HF (I50) as used in this analysis is identical to I50 using ICD-10-WHO. As a sole exception, since 2005 ICD-10-GM demands classification of HF caused by hypertension and HF caused by hypertension with renal disease as I50, while ICD-10-WHO continued to encode these diagnoses as I11 and I13, respectively.
Data represent a census of all in-hospital patients in Germany between 2000 and 2013 and do not represent a sample or a representative subgroup. Thus, data of all cases fulfilling the selection criterion (ICD-10-GM: I50) are presented as frequencies without confidence intervals. Because of the full census of data, comparisons using statistical tests are not needed. In the context of our evaluation, the data based on the primary discharge diagnosis code I50 are referred to as 'HF-related'. Disease classification and coding as well as all individual patient's data ascertainment are performed at the hospital level using predefined and uniform criteria throughout the study period. The Federal Statistical Office, in collaboration with the State Statistical Offices, accounted for data compilation, processing, and publishing; no external validation of these data is available. The data presented are in good accord with the GePaRD (German Pharmacoepidemiological Research Database) dataset and have been used as reference for the GePaRD dataset validation. 5 German data show that an internal confirmation of inpatient diagnoses of HF was possible in 98% of cases. 6 whether settlement instructions within the German health-care system ('diagnosis-related groups', DRG) have any effect on the coding of discharge diagnosis.
Owing to migration to and from Germany, data are presented as absolute number of cases reported per year (irrespective of the place of residence) and/or as rates per 100 000 population. Inference of the number of affected individual patients is not feasible. In addition, the data presented on HF-related admissions were age-standardized to the most recent standard population of 'Germany 1987' as provided by the German Federal Health Monitoring System (age-standardization is offered exclusively for admission data).
Results
Trends in hospitalization for heart failure
The absolute number of hospitalizations owing to HF increased from 239 694 in 2000 to 396 380 in 2013 (65.4%; Figure 1 ). After age-standardization, the increase in HF-related hospitalizations was 28.4% (i.e. from 261 to 335 per 100 000 population; Figure 2a ). Across all age groups, the rate of HF-related hospitalizations per 100 000 population was consistently higher for male than for female patients. However, the increase in HF-related hospitalization rates was more pronounced in men (men 33.2%, women 21.2%). Sex-specific increase in HF-related admission rates was found in most age groups (Figure 2b) .
Between 2000 and 2013, approximately two-thirds of patients diagnosed with HF were aged ≥75 years; in 2013, 31% vs. 69% of HF-related hospitalizations occurred in patients aged <75 years vs. ≥75 years, respectively. Only a few HF cases were reported in patients aged <45 years ( Figure 3 ). There was a significant increase in HF-related hospitalizations across all age groups, the most pronounced being in the age group 75 to <85 years (89.6%), followed by the age group ≥85 years (62.6%). Using narrower age categories does not meaningfully alter these findings.
Comparison of heart failure-related and overall disease-related trends
Long-term trends of HF-related hospitalizations and hospital days substantially differed from those found for all discharge diagnoses in Germany during the observation period ( Figure 1 In 2013, a total of 2.1% of all hospitalizations, 2.9% of all hospital days, and 8.8% of all in-hospital deaths were related to HF (see the Supplementary material online, Figure S1 ), resulting from continuously rising numbers of HF cases and constant numbers of HF-related in-hospital deaths. Accordingly, HF was the most common cause of disease-related hospitalization, the second leading cause of hospital days (preceded by the diagnosis of recurrent depressive disorder), and the leading cause of in-hospital deaths in 2013, followed by pneumonia, acute myocardial infarction, and neoplasms of bronchus and lung ( Table 1) .
Heart failure-related hospital days and length of stay
In 2000, the absolute number of HF-related hospital days (3.4 million) had been substantially lower for male than for female HF patients (1.4 vs. 2.0 million). Until 2013, the increase in the number of HF-related hospital days was more pronounced in male patients (46.4%) than in female patients (5.3%). Hence, sex-based differences were nullified and the absolute number of HF-related hospital days was 2.1 million for both male and female patients (total: 4.2 million; see the Supplementary material online, Table  S1 ). During the same period, the average length of stay for HF patients decreased from 14.3 days to 10.6 days (total −25.9%; female −28.1%, male −23.7%), paralleling and even exceeding the overall decrease of the average length of stay for any diagnosis from 9.7-7.6 days (total −21.6%; female −21.6%, male −21.9%; see the Supplementary material online, Table S2 ). As patient age and average length of stay did not correlate, the number of hospital days per age group corresponds to the number of cases, as represented above.
. 
In-hospital deaths
Between 2000 and 2013, the annual number of HF-related in-hospital deaths remained consistently high (in 2013 there were 36 717 deaths: i.e. 45 per 100 000 population). Absolute numbers and the rate of in-hospital death per 100 000 population were consistently higher in female HF patients than in male HF patients (see the Supplementary material online, Figure S2 and Table S3 ).
In 2013, the absolute number of HF-related in-hospital deaths comprised 19 749 female and 16 968 male patients. Thus, the male proportion increased from 41.1% in 2000 to 46.2% in 2013 (see the Supplementary material online, Figure S2 ). In 2013, there were 48 vs. 43 HF-related in-hospital deaths per 100 000 population in women and men, respectively (see the Supplementary material online, Table S3 ). Overall, in-hospital mortality rate in HF inpatients dropped from 14.8% in 2000 to 9.3% in 2013 (female 9.7%, male 8.8%). In 2013, HF mortality accounted for 8.8% of all cases of in-hospital deaths with marked differences in the rates between female and male patients (9.8% vs. 7.8%; see the Supplementary material online, Figure S2 ). Within each age group, the number of HF-related in-hospital deaths per 100 000 population declined between 2000 and 2013, with less pronounced declines in older age groups (see the Supplementary material online, Table S3 ). Heart failure disproportionately affected elderly people, as is evident from the higher numbers of admissions, hospital days, and of in-hospital deaths (Figure 3 , see the Supplementary material online, Tables S1 and S3).
Discussion
The present study analysed temporal trends of HF burden in Germany yielding the following main results: (i) in contrast to the Germany. 7 Heart failure disproportionately affects older patients supporting the need for improvement of HF care, particularly in this population.
In 2013, HF accounted for 2.1% of all hospitalizations, 2.9% of all hospital days and 8.8% of in-hospital deaths in Germany. These data support the notion that HF-related hospitalizations are frequent and that HF is the major reason for in-hospital mortality. Table 1 ). Heart failure was also the leading cause of in-hospital death-considerably higher than pneumonia and acute myocardial infarction, which account for 28% and 45% less in-hospital deaths, respectively, compared with HF. In summary, the burden of HF remains excruciatingly high and is associated with very high health-care costs. Although we cannot provide further data on hospital costs on HF-related hospitalization or health-care expenditure, the cost of care for HF patients is estimated to be over 2.9 billion euros in Germany. 7 Hospitalizations account for the majority of the economic burden of HF care, 1,7 which represents about 1-3% of total health-care expenditure in developed countries and is expected to rise further.
1
Heart failure is a clinical syndrome and a high proportion of HF cases may result from previous myocardial infarction. However, the source of the data presented does not allow further conclusion because of the lack of coding of HF aetiology. Future studies may analyse further details and relations in order to improve the prevention of HF and related morbidity and mortality. 
In-hospital mortality
Between 2000 and 2013, the annual absolute number of HF-related in-hospital deaths in Germany remained consistently high at approximately 35 000. Owing to the steady increase in hospitalizations for HF, the in-hospital mortality rate in HF patients has continuously declined. In face of the recent efforts aimed at improving prevention, diagnosis and management of HF, the number of HF-related in-hospital deaths and its 8.8% share in the total in-hospital mortality are still alarmingly high and HF remains the leading cause of in-hospital deaths. In addition, the reduction in the length of hospital stay of HF patients may relate to higher frequencies of adverse post-discharge events, including HF-related death. 8 An observational study of 6 955 461 Medicare fee-for-service hospitalizations for HF in the USA showed that reduction of length of stay was associated with a steady decline in in-hospital mortality. This 28.1% considerable reduction of length of stay (roughly 9-6 days) was associated with a continuous rise in post-discharge mortality. 8 Dutch data report a positive association between in-hospital mortality rate and length of hospital stay, and an inverse association between in-hospital mortality rate and early post-discharge mortality 9 corroborating HF-specific US data.
10 Indeed, we also observed a >25% reduction in length of hospital stay and a significant decline in in-hospital mortality rate in HF patients. However, data on post-discharge mortality are lacking in Germany. Thus, we cannot elucidate whether or not this also translates into benefits or even disadvantages in 30-day mortality risk and propose to implement measures to survey the overall quality of health-care in HF patients.
Age-and sex-related aspects
Most HF-related hospitalizations, hospital days, and in-hospital deaths occurred in adults aged >65 years, reflecting both the nature of the disease as well as the aging population with the associated burden of co-morbidities in an industrialized country.
11 Improved conditions of living, in addition to successful preventive measures and medical and non-medical management of other cardiac diseases such as acute myocardial infarction, improved survival but mediated a subsequently increased susceptibility of survivors to HF.
1,2
Nowossadeck
11 showed that increases in HF-related hospitalizations in Germany between 2000 and 2009 (+51.9%) were caused not only by demographic aging (+22.0%) but also by changed risk patterns for hospitalization (+24.5%). In the present study, the increase in HF-related hospitalizations per 100 000 population between 2000 and 2013 was 28.4% after age-standardization, thus suggesting yet to be identified additional mechanisms that are at least partly responsible for the increase in HF hospitalizations in Germany.
Correlation with other diagnoses is not feasible because of the database structure in Germany. We hypothesize that socioeconomic factors as well as changes in risk patterns (e.g. improved survival of acute myocardial infarction resulting in increased susceptibility to HF) are possible contributors. In addition, increases in age-standardized HF-related hospitalization may reflect changes in hospitalization patterns and/or an increase in re-hospitalizations owing to factors such as reduction in length of stay or a better survival in preceding admissions for worsening HF, or a potential increase in preventable or avoidable hospital admissions. Our analysis also shows that in 2013, middle-aged patients <75 years contributed to more than 120 000 HF-related hospitalizations and almost 1.3 million hospital days, respectively.
In 2000, the proportion of female patients hospitalized for HF was considerably higher than that of male patients. In line with Nowossadeck, 11 we are convinced that this reflects an imbalanced sex distribution in the elderly resulting from a more distinct . Similarly, HF-related in-hospital deaths in female patients were consistently higher but tended to converge with those of male patients, which may predominantly reflect the demographic trends already mentioned. Despite the apparently higher proportion of HF mortality in female patients (see the Supplementary material online, Figure S1 and S2C), the higher number of male patients affected in each individual age group per 100 000 population (Figure 2) suggests the disproportionate aging patterns in male and female patients as a plausible explanation.
does not apply to either the total number of HF-related hospital days (a composite measure per se) or the number of in-hospital deaths (an individual event). Third, the ICD-10 modification and the concurrent introduction of the DRG renumeration system in Germany may have contributed to the observed deviation in HF trends occurring in 2004. Further limitations may relate to coding errors and evolving coding practices. 2 The validation of HF diagnosis, as adjudicated by discharging, is considered high and studies reported positive predictive values of >90%. 26 In addition, criteria for HF diagnosis were statutorily regulated. In summary, we are convinced that this large dataset and the representative character of these data facilitate valuable insights into current trends of HF burden in Germany and might also add information for extrapolation to Europe in general.
Conclusion
The absolute number of HF cases and related hospital days in Germany considerably increased between 2000 and 2013, whereas the number of HF-related deaths remained consistently high. These findings support the profound impact exerted by HF on both the patients and the health-care system. The increasing burden of HF necessitates a further increase in awareness for this disease and underscores an urgent need for improved diagnostic, therapeutic, and preventive strategies.
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